Forbion European Acquisition Corp. (NASDAQ:FRBN) announced that its shareholders approved its combination with biotech firm enGene at a special meeting held earlier today.
In connection with the meeting, FEAC’s public shareholders holding 10,379,144 Class A ordinary shares elected to redeem their shares.
The parties expect to close the business combination on or about October 31, subject to the satisfaction or waiver of the conditions with respect to the deal.
Forbion originally brought about $133 million into the deal from its trust, including $20 million in Class A shares held by its sponsor, Forbion Growth, and 166,665 shares already covered by a non-redemption agreement.
The SPAC supplemented this with a $56.9 million PIPE at $10.25 per share that drew the participation of institutional and strategic investors including BVF Partners, Omega Funds, Cowen Healthcare Investments, Investissement Québec, Vivo Capital, Northleaf Capital Partners and CTI Life Sciences.
Forbion European inked its deal with enGene earlier this year in May. Montreal-based company enGene is developing non-viral gene therapies to treat cancers and other conditions.
Columbus Circle Capital Corp I (NASDAQ:CCCMU) announced the pricing of its upsized $220 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CCCMU”, Friday, May 16, 2025. The new SPAC aims to conduct a broad search for a target with a team that has expertise in telecoms, media,...
Wen Acquisition Corp (NASDAQ:WENNU) announced the pricing of its $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “WENNU”, Friday, May 16, 2025. The new SPAC aims to combine with a fintech target focused on enabling digital assets through the integration of blockchain networks into traditional financial...
Blue (NYSE:BACCU) has filed for a $150 million SPAC that will take a generalist search process, but it hopes to come down with an industrial target. The new SPAC is the 11th in a row to file without an offer to overfund its trust. It offers investors one right to a 1/10 share in each...
Axiom Intelligence Acquisition Corp. 1 (NYSE:AXINU) has filed for a $150 million SPAC that will look for opportunities among infrastructure targets in both the physical and digital spheres. The new SPAC is not overfunded and has one right to a 1/10 share in each unit with 24 months to initially complete a business combination. The...
At the SPAC of Dawn After several days of rallying, US futures are red in anticipation of Core PPI readings this morning followed by a raft of industrial and home-building indicators. In the meantime, several de-SPACs have continued to report notable results in their latest earnings. Automotive parts firm Carbon Revolution (NASDAQ:CREV) achieved record revenue...